Evidence map›Paper›PMID 19394543›Full record

Trial reportJournal of vascular surgery2009

Systemic inflammation, coagulopathy, and acute renal insufficiency following endovascular thoracoabdominal aortic aneurysm repair.

Catherine K Chang, Timothy A M Chuter, Claus U Niemann, Michael G Shlipak, Mitchell J Cohen, Linda M Reilly, Jade S Hiramoto

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Journal of vascular surgery, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03208920 (Omega EVAR), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03208920 nacompletednot on this mapstarted 2016, after this paper: background citation

Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.

TypeinterventionalSponsorUniversity of California, San FranciscoRan2016 to 2018Enrolled2ConditionsPAD, Abdominal Aortic AneurysmArmsPro-Omega, ProOmega Placebo
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Catherine K ChangDepartment of Surgery, Division of Vascular Surgery, University of California at San Francisco, San Francisco, Calif. 94143-0222 , USA.
Timothy A M Chuter
Claus U Niemann
Michael G Shlipak
Mitchell J Cohen
Linda M Reilly
Jade S Hiramoto
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

CTSA: K12 COMPONENTKL2RR024130 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$19.3M
Mechanism of Traumatic CoagulopathyK08GM085689 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, MITCHELL · 2008 to 2012
$594k
NCRR NIH HHS KL2 RR024130NCRR NIH HHS RR024130NIGMS NIH HHS K08 GM-085689NIGMS NIH HHS K08 GM085689
6 · The paper itself

Abstract

objectiveTo characterize the inflammatory and coagulopathic response after endovascular thoracoabdominal aortic aneurysm (TAAA) repair and to evaluate the effect of the response on postoperative renal function.

methodsFrom July 2005 to June 2008, 42 patients underwent elective endovascular repair of a TAAA using custom designed multi-branched stent-grafts at a single academic institution. Four patients were excluded from the analysis. White blood cell count (WBC), platelet count, prothrombin time (PT), and creatinine were measured in all patients. In the last nine patients, interleukin-6 (IL-6), protein C, Factor V, d-dimers, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) levels were also measured. Change in lab values were expressed as a percentage of baseline values.

resultsThe 30-day mortality rate was 5% (2/38). All patients (n = 38) had a higher WBC (mean +/- SD: 139 +/- 80%, P < .0001), lower platelet count (56 +/- 15%, P < .0001), and higher PT (median: 17%, Interquartile range (IQR) 12%-22%, P < .0001) after stent-graft insertion. Twelve of 38 patients (32%) developed postoperative acute renal insufficiency (>50% rise in creatinine). Patients with renal insufficiency had significantly larger changes in WBC (178 +/- 100% vs 121 +/- 64%, P = .04) and platelet count (64 +/- 17% vs 52 +/- 12%, P = .02) compared with those without renal insufficiency. All patients (n = 9) had significant increases in NGAL (182 +/- 115%, P = .008) after stent-graft insertion. Six of nine patients (67%) had increased cystatin C (35 +/- 43%, P = .04) after stent-graft insertion, with a greater rise in those with postoperative renal insufficiency (87 +/- 32% vs 8 +/- 13%, P = .02). IL-6 levels were markedly increased in all patients (n = 9) after repair (9840 +/- 6160%, P = .008). Protein C (35 +/- 10%, P = .008) and Factor V levels (28 +/- 20%, P = .008) were uniformly decreased, while d-dimers were elevated after repair in all patients (310 +/- 213%, P = .008).

conclusionsLeukocytosis and thrombocytopenia were uniform following endovascular TAAA repair, and the severity of the response correlated with post-operative renal dysfunction. Elevation of a sensitive marker of renal injury (NGAL) suggests that renal injury may occur in all patients after stent-graft insertion.

Indexed as

Acute Kidney InjuryAcute-Phase ProteinsAgedAged, 80 and overAortic Aneurysm, ThoracicBiomarkersBlood Coagulation DisordersBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationCreatinineCystatin CFactor VFemaleFibrin Fibrinogen Degradation ProductsHumansInterleukin-6Acute-Phase ProteinsBiomarkersCreatinineCST3 protein, humanCystatin CFactor VFibrin Fibrinogen Degradation Productsfibrin fragment DIL6 protein, humanInterleukin-6LCN2 protein, humanLipocalin-2LipocalinsProtein CProto-Oncogene Proteins

Identifiers

PMID19394543
PMCPMC3276362
OpenAlexW2123787723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.